Provided by Tiger Trade Technology Pte. Ltd.

NeoGenomics

16.98
+0.45002.72%
Pre-market: 17.030.0500+0.29%05:25 EDT
Volume:1.14M
Turnover:19.23M
Market Cap:2.17B
PE:-42.21
High:17.08
Open:16.60
Low:16.21
Close:16.53
52wk High:17.08
52wk Low:6.38
Shares:128.00M
Float Shares:117.00M
Volume Ratio:0.78
T/O Rate:0.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4023
EPS(LYR):-0.8433
ROE:-6.33%
ROA:-1.89%
PB:2.77
PE(LYR):-20.14

Loading ...

NeoGenomics Inc. Earnings Call Signals Strong Clinical Push

TIPRANKS
·
Aug 15

NEO Battery Raises $4 Million to Expand South Korean Battery Manufacturing

TIPRANKS
·
Aug 15

Stifel Nicolaus Keeps Their Buy Rating on Neo Performance Materials Inc (NEO)

TIPRANKS
·
Aug 12

NeoGenomics Announces Planned Transition of General Counsel Role

TIPRANKS
·
Aug 12

NEO Battery Amends $4 Million LIFE Offering to Fund South Korea Expansion

TIPRANKS
·
Aug 08

NeoGenomics Chief Accounting Officer Greg D. Aunan Disposes of 20,000 Shares for $321,400

Reuters
·
Aug 07

Deltic Energy sets remote court hearing as NEO NEXT+ cash takeover nears completion

TIPRANKS
·
Aug 06

How NeoGenomics’ Q2 Profit Return And Higher 2026 Outlook At NeoGenomics (NEO) Has Changed Its Investment Story

Simply Wall St.
·
Aug 06

Veracyte Q2 Revenue Rises on Decipher and Afirma Test Sales

Reuters
·
Jul 31

Fulgent Genetics Q2 Revenue Rises 20% Sequentially, Sees Billing System Transition Delay

Reuters
·
Jul 31

CareDx Q2 Revenue Beats Estimates; Outlook Lifted

Reuters
·
Jul 31

NeoGenomics (NEO) Stock Rallies As Profit Returns And Margins Improve

Simply Wall St.
·
Jul 30

Update: NeoGenomics Shares Rise After Q2 Beat

MT Newswires Live
·
Jul 30

NeoGenomics price target raised to $19 from $17 at Craig-Hallum

TIPRANKS
·
Jul 29

Needham Raises Price Target on NeoGenomics to $19 From $15, Keeps Buy Rating

MT Newswires Live
·
Jul 29

Neogenomics Inc : Needham Raises Target Price to $19 from $15

THOMSON REUTERS
·
Jul 29

NeoGenomics is Maintained at Buy by Needham

Dow Jones
·
Jul 29

Neogenomics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 29

GUIDANCE: (NEO) NeoGenomics Expects 2026 Revenue Range $802 Million-$806 Million, vs. FactSet Est of $800.4 Million

MT Newswires Live
·
Jul 29

Earnings Flash (NEO) NeoGenomics Posts Q2 Adjusted EPS $0.05, vs. FactSet Est of $0.03

MT Newswires Live
·
Jul 29